Abstract:
The invention provides anti-ETBR antibodies and immunoconjugates and methods of using the same. In some embodiments, an immunoconjugate comprising an antibody that binds ETBR covalently attached to a cytotoxic agent is provided, wherein the antibody binds an epitope within amino acids 64 to 101 of SEQ ID NO: 10. In some embodiments, the cytotoxic agent is a pyrrolobenzodiazepine.
Abstract translation:本发明提供抗ETBR抗体和免疫缀合物及其使用方法。 在一些实施方案中,提供了包含结合与细胞毒性剂共价连接的ETBR的抗体的免疫偶联物,其中所述抗体结合SEQ ID NO:10的氨基酸64至101内的表位。在一些实施方案中,细胞毒性剂是吡咯并苯并二氮杂 。
Abstract:
The invention provides therapeutic combinations of anti-ETBR antibodies and MAP kinase inhibitors and methods of using the same to treat melanoma.
Abstract:
The invention provides anti-ETBR antibodies and immunoconjugates and methods of using the same. In some embodiments, an immunoconjugate comprising an antibody that binds ETBR covalently attached to a cytotoxic agent is provided, wherein the antibody binds an epitope within amino acids 64 to 101 of SEQ ID NO: 10. In some embodiments, the cytotoxic agent is a nemorubicin derivative.
Abstract translation:本发明提供抗ETBR抗体和免疫缀合物及其使用方法。 在一些实施方案中,提供包含结合与细胞毒性剂共价连接的ETBR的抗体的免疫偶联物,其中所述抗体结合SEQ ID NO:10的氨基酸64至101内的表位。在一些实施方案中,细胞毒性剂是尼莫尿 衍生物。
Abstract:
The invention provides anti-ETBR antibodies and immunoconjugates and methods of using the same. In some embodiments, an immunoconjugate comprising an antibody that binds ETBR covalently attached to a cytotoxic agent is provided, wherein the antibody binds an epitope within amino acids 64 to 101 of SEQ ID NO: 10. In some embodiments, the cytotoxic agent is a pyrrolobenzodiazepine.
Abstract translation:本发明提供抗ETBR抗体和免疫缀合物及其使用方法。 在一些实施方案中,提供了包含结合与细胞毒性剂共价连接的ETBR的抗体的免疫偶联物,其中所述抗体结合SEQ ID NO:10的氨基酸64至101内的表位。在一些实施方案中,细胞毒性剂是吡咯并苯并二氮杂 。
Abstract:
The invention provides anti-ETBR antibodies and immunoconjugates and methods of using the same. In some embodiments, an immunoconjugate comprising an antibody that binds ETBR covalently attached to a cytotoxic agent is provided, wherein the antibody binds an epitope within amino acids 64 to 101 of SEQ ID NO: 10. In some embodiments, the cytotoxic agent is a nemorubicin derivative.
Abstract translation:本发明提供抗ETBR抗体和免疫缀合物及其使用方法。 在一些实施方案中,提供包含结合与细胞毒性剂共价连接的ETBR的抗体的免疫偶联物,其中所述抗体结合SEQ ID NO:10的氨基酸64至101内的表位。在一些实施方案中,细胞毒性剂是尼莫尿 衍生物。